Ramipril

Product manufactured by Proficient Rx Lp

Application Nr Approved Date Route Status External Links
ANDA077626 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1. Indications And Usage • Ramipril Capsules Usp Are Indicated For The Treatment Of Hypertension. It May Be Used Alone Or In Combination With Thiazide Diuretics. ( 1.1 ). • Ramipril Capsules Usp Are Indicated In Stable Patients Who Have Demonstrated Clinical Signs Of Congestive Heart Failure Post-Myocardial Infarction ( 1.3 ). 1.1 Hypertension Ramipril Capsules Usp Are Indicated For The Treatment Of Hypertension. It May Be Used Alone Or In Combination With Thiazide Diuretics. 1.3 Heart Failure Post-Myocardial Infarction Ramipril Capsules Usp Are Indicated In Stable Patients Who Have Demonstrated Clinical Signs Of Congestive Heart Failure Within The First Few Days After Sustaining Acute Myocardial Infarction. Administration Of Ramipril To Such Patients Has Been Shown To Decrease The Risk Of Death (Principally Cardiovascular Death) And To Decrease The Risks Of Failure-Related Hospitalization And Progression To Severe/resistant Heart Failure [See Clinical Studies ( 14.3 ) ].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ramipril RAMIPRIL ZINC3798757

Comments